
A recent Smithsonian article described how a microscopic fungus survived conditions designed to sterilise spacecraft. At first glance, this might sound like a story about space exploration rather than human health. But for people living with aspergillosis, it carries an important and surprisingly positive message.
Fungi are remarkable survivors
The article describes research showing that some Aspergillus spores can survive extreme conditions, including harsh radiation, dryness and cleaning procedures. This does not mean that aspergillosis patients need to worry about “space fungi”. Instead, it highlights something patients and specialists already understand very well: fungi are extraordinarily resilient organisms.
Aspergillus spores are common in the environment. They can be found in soil, compost, decaying leaves, dust, damp buildings and sometimes even very clean environments. Most people breathe in small numbers of spores every day without becoming ill, because their lungs and immune system clear them effectively.
For people with lung disease, asthma, immune system problems or damaged lung tissue, however, Aspergillus can sometimes cause illness. This includes conditions such as chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitisation.
A positive message for patients
One positive message from this research is that aspergillosis is not caused by weakness, poor hygiene or personal failure. Fungi are genuinely formidable organisms. If some fungal spores can survive environments as extreme as those used in space research, it becomes easier to understand why completely avoiding Aspergillus in everyday life is difficult.
This can be reassuring for patients who feel frustrated when symptoms persist despite doing “everything right”. It is not that they are failing. It is that fungal biology is complex, and fungal exposure is part of the natural world.
Why this matters emotionally
Many people with aspergillosis say they feel misunderstood. They may hear comments such as:
- “It’s only mould.”
- “Surely it should have cleared by now.”
- “Why are you still worrying about it?”
Stories like this help show that fungi are not simple or trivial. They are ancient, adaptable and scientifically fascinating organisms. Aspergillosis is therefore not “just mould exposure”; it is a real medical condition involving a complex interaction between the fungus, the lungs and the immune system.
Science is taking fungi more seriously
Another encouraging message is that fungi are attracting more scientific attention. Researchers are studying fungal survival, environmental spread, resistance to treatment, and the ways fungi interact with humans and indoor environments.
This matters because better understanding can lead to better diagnosis, better treatment and better prevention. In recent years, fungal medicine has already benefited from improvements in CT scanning, fungal blood tests, respiratory samples, antifungal treatments and biologic medicines for some allergic forms of disease.
Resilience goes both ways
The story also offers a useful reflection: fungi are resilient, but so are patients.
Many people living with aspergillosis adapt to long-term symptoms, hospital appointments, uncertainty, fatigue and treatment decisions. They continue to work, care for families, attend support groups, learn about their condition and help others understand fungal disease.
That resilience deserves recognition.
What patients can take from this
- Aspergillus is difficult to avoid completely, so exposure reduction should be realistic rather than perfectionist.
- Persistent symptoms are not a personal failure; fungal diseases can be complex and long-lasting.
- Fungal science is advancing, and aspergillosis is increasingly recognised as an important medical condition.
- Patients’ experiences are valid, even when others do not fully understand them.
When to seek medical advice
People with aspergillosis or suspected aspergillosis should seek medical advice if they develop worsening breathlessness, coughing up blood, unexplained weight loss, persistent fever, chest pain, a major change in sputum, or a significant deterioration in day-to-day symptoms.
Anyone already under specialist care should follow their agreed care plan and contact their clinical team if symptoms change significantly.
Further reading
- Smithsonian Magazine: fungus surviving spacecraft sterilisation conditions
- Aspergillosis.org: patient information and support
Last reviewed: May 2026
Share this post
Latest News posts
Could diarrhoea on itraconazole be C. diff?
April 20, 2026
What if you can’t tolerate azole antifungal medicines?
April 16, 2026
Weekly Aspergillosis Research Update (7–11 April 2026)
April 13, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
